MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$873,467
Loss from continuing
operations
-$873,467
Interest income, net
$21,663
Loss before other
income (expense)
-$895,130
Total operating
expenses
$895,130
General and
administrative
$833,304
Research and development
$61,826
Back
Back
Income Statement
source: myfinsight.com
Salarius Pharmaceuticals, Inc. (SLRX)
Salarius Pharmaceuticals, Inc. (SLRX)